Benzinga | Nov 5, 2020 07:08AM EST

Axsome Therapeutics Q3 EPS $(0.61) Misses $(0.57) Estimate

Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.57) by 7.02 percent. This is a 8.93 percent decrease over losses of $(0.56) per share from the same period last year.